Medi Assist Healthcare Services has approved an investment to increase its stake in its UK subsidiary, Mayfair We Care Limited, to 91.75% for a consideration of GBP 589,270. The acquisition of 1,270 ordinary shares, representing a 31.75% additional shareholding, was approved by the Board on June 24, 2026. This strategic move deepens the company's foothold in international markets and aligns with its long-term vision of delivering cross-border health administration services.

The transaction involves the purchase of shares from existing shareholders of Mayfair. Upon completion, Medi Assist Healthcare Services' shareholding will rise from the current 60% to 91.75% of the issued share capital. The acquisition is expected to be finalized by the end of the second quarter of FY 2026-27, subject to customary closing formalities.

Mayfair We Care Limited operates in the insurance intermediary sector, providing health claim and health benefits administration services to the global health insurance market. For the financial year ending March 31, 2026, the entity reported a turnover of INR 410.85 Million and a net profit of INR 16.31 Million.

Financial Performance of Mayfair We Care Limited

The transaction will be executed through a cash consideration funded by proceeds raised via preferential allotment allocated for general corporate purposes. The company stated that utilizing these funds for the investment does not deviate from the objects approved by shareholders.

Leadership changes within Mayfair will accompany the acquisition. Mr. Nikhil Chopra, currently the Chief Business Officer of Medi Assist Healthcare Services and Director of Mayfair, will be appointed as CEO-designate. He will assume the role of CEO upon the transaction's completion. Concurrently, Mr. Michail Chopra will transition from CEO to Founder & Strategic Advisor.

Medi Assist Healthcare Services has informed the stock exchanges regarding the status of the Scheme of Amalgamation between its wholly owned subsidiaries, International Healthcare Management Services Private Limited and Mayfair Consultancy Services India Private Limited. In a regulatory filing dated May 20, 2026, the company disclosed that the Regional Director, South Western Region, Bengaluru, has referred the matter to the Hon'ble National Company Law Tribunal (NCLT), Bengaluru.

The Regional Director's order, dated May 19, 2026, highlighted that the application for the fast-track merger under Section 233 of the Companies Act, 2013, was not in compliance with statutory pre-conditions. Specifically, the order noted that a general meeting of the shareholders was not conducted as required under Section 233(1)(b) of the Act. Furthermore, the scheme did not provide for consideration or a share swap ratio backed by a valuation report, which resulted in a reduction of the share capital of the Transferee Company.

The authorities observed that the scheme, as presented, did not qualify for the fast-track merger route. Consequently, the Regional Director rejected the RD-1 form and forwarded the application to the NCLT, Bengaluru, for consideration under Section 232 of the Companies Act, 2013. The company clarified that the Scheme of Amalgamation is an internal restructuring process and that this order does not impact the consolidated financial statements of Medi Assist Healthcare Services Limited.

The following table outlines the key entities involved in the scheme:

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE456Z01021/d619c5fa6a2340c0.pdf